Background: The efficacy of chemotherapy in patients with large cell neuroendocrine carcinoma of the lung (LCNEC) remains unclear. Methods: Of 42 consecutive patients with LCNEC, 22 with measurable disease receiving chemotherapy were enrolled as the subjects of this study. The clinical characteristics and objective responses to chemotherapy in these patients were analysed retrospectively. Results: The distribution of the disease stage in the patients consisting of 21 males and on
International audienceINTRODUCTION: The optimal management of large cell neuroendocrine cancer of th...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...
Background: The efficacy of chemotherapy in patients with large cell neuroendocrine carcinoma of the...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
IntroductionWe conducted a phase II study of combination chemotherapy with irinotecan (CPT) and cisp...
Pulmonary large cell neuroendocrine carcinoma (LCNEC), which accounts for approximately 1% of all lu...
Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive biological b...
Hong Tang,1 Hongyan Wang,1 Shaoyan Xi,2 Chunyu He,3 Yuxi Chang,4 Qiming Wang,1 Yufeng Wu1 1Departme...
BJECTIVES: Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive b...
Shinichiro Ryuge1, Shi-Xu Jiang2, Mayuko Wada1, Ken Katono1, Maiko Iwasaki1, Akira Takakura1, Sakiko...
OBJECTIVES: Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive ...
Lung large cell neuroendocrine carcinoma (L-LCNEC) is a rare, aggressive, and difficult-to-treat tum...
International audienceINTRODUCTION: The optimal management of large cell neuroendocrine cancer of th...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...
Background: The efficacy of chemotherapy in patients with large cell neuroendocrine carcinoma of the...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ran...
IntroductionWe conducted a phase II study of combination chemotherapy with irinotecan (CPT) and cisp...
Pulmonary large cell neuroendocrine carcinoma (LCNEC), which accounts for approximately 1% of all lu...
Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive biological b...
Hong Tang,1 Hongyan Wang,1 Shaoyan Xi,2 Chunyu He,3 Yuxi Chang,4 Qiming Wang,1 Yufeng Wu1 1Departme...
BJECTIVES: Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive b...
Shinichiro Ryuge1, Shi-Xu Jiang2, Mayuko Wada1, Ken Katono1, Maiko Iwasaki1, Akira Takakura1, Sakiko...
OBJECTIVES: Large-cell neuroendocrine carcinoma (LCNC) is a rare tumour characterized by aggressive ...
Lung large cell neuroendocrine carcinoma (L-LCNEC) is a rare, aggressive, and difficult-to-treat tum...
International audienceINTRODUCTION: The optimal management of large cell neuroendocrine cancer of th...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...
Lung neuroendocrine tumors are a heterogeneous subtype of pulmonary cancers representing approximate...